Regenics vs TMates: pricing, meds, and clinician access compared
Regenics vs TMates: quick verdict — Regenics is the lower promotional entry price with nurse-practitioner-led telehealth and an added Sermorelin option, while TMates offers a flat $199/month rate with 24/7 U.S. doctor access and same price at every dose. Treatment availability for both is subject to clinician review and compounded medications are not FDA-approved.
Start Regenics from $139 first month
Direct comparison: pricing model and what you pay
Price is one of the clearest differences in the Regenics vs TMates comparison. Regenics advertises compounded semaglutide starting at $139 for the first month and tirzepatide at $189 for the first month, with renewal prices listed as higher. TMates advertises a flat $199/month price that remains the same at every dose, with no step-up fees as dosage escalates.
How promotions and renewals differ
Regenics notes promotional pricing applies to the first month only and renewal pricing increases to the stated monthly rates. TMates emphasizes a single flat monthly price for semaglutide programs so cost does not increase during titration.
Clinical oversight and access
Clinician access is another major distinction. Regenics’ care is delivered by licensed nurse practitioners who review intake before anything is prescribed. TMates highlights 24/7 access to U.S.-based doctors across all 50 states and includes virtual check-ins and physician availability beyond messaging.
See TMates with 24/7 U.S. doctor access
Medication selection and formulation
Both providers supply compounded semaglutide and state their medications are formulated in U.S. facilities, but the pair differs in public detail. Regenics explicitly offers compounded semaglutide and tirzepatide plus a Sermorelin peptide option. TMates markets clinically dosed compounded semaglutide with limited public detail on tirzepatide availability.
Quality, regulatory notes, and shipping
Both platforms use compounded medications and include the regulatory qualifier that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. Regenics states its pharmacy network is LegitScript certified and offers free shipping with medications compounded in the USA. TMates also offers free shipping and emphasizes U.S.-formulated medications.
Availability and best use cases
TMates advertises licensed coverage in all 50 states and direct physician availability. Regenics is telehealth-only; treatment is available only when a licensed clinician determines it is medically appropriate. Neither provider’s materials on the captured pages guarantee in-person clinics.
| Criteria | Regenics | TMates |
|---|---|---|
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | $199/month flat, same price at every dose |
| Pricing model over time | Promotional first month; higher renewal rates (e.g., $199 semaglutide) | Flat monthly rate with no step-up fees |
| Clinician access | Licensed nurse practitioners review intake and oversee prescriptions | 24/7 access to U.S.-based doctors and virtual check-ins |
| Medications offered | Compounded semaglutide, tirzepatide, plus Sermorelin peptide | Clinically dosed compounded semaglutide; limited public detail on tirzepatide |
| Pharmacy and formulation | Compounded in U.S. pharmacies; LegitScript certified network | Formulated in U.S.-based facilities; compounded medication |
| Regulatory note | Compounded meds are not FDA-approved finished products | Compounded meds are not FDA-approved finished products |
Patient considerations when choosing
Decide which aspects matter most: if initial price is your priority and you want a peptide add-on, Regenics presents a lower first-month entry and offers Sermorelin. If consistent monthly billing and round-the-clock access to U.S. doctors across all states is more important, TMates provides a flat $199/month model with 24/7 physician availability. Both require clinician review for eligibility and both use compounded medications that are not FDA-approved as finished products.
Choose Regenics for lower first-month pricing
Conclusion
In this Regenics vs TMates comparison, Regenics stands out for promotional entry pricing and an added peptide offering with nurse-practitioner-led telehealth; TMates stands out for a predictable flat $199/month price and 24/7 U.S. doctor access. Both use compounded semaglutide and note that compounded medications are not FDA-approved.
Choose Regenics if…
you want a lower promotional first month for semaglutide or tirzepatide, value a nurse-practitioner-led telehealth model, and are interested in an offered Sermorelin peptide option.
Choose TMates if…
you prefer a flat monthly price that does not increase at higher doses and want 24/7 access to U.S.-based doctors across all 50 states.